amphetamine

Drug ingredientActive Shortage

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 300-62-9

Where It Comes From

4 FDA-registered drug labelers
Neos Therapeutics Brands, LLC
Neos Therapeutics, LP
NextWave Pharmaceuticals, Inc
Teva Pharmaceuticals, Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 4 drug and cosmetic product listings (FDA).

  • Amphetamine Extended-Release
  • Amphetamine
  • Dyanavel XR
  • Adzenys XR-ODT
FDA Shortage Status
Active Shortage
Shortage History
current

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

10/12/2022

Available

current

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

10/12/2022

Limited Availability

current

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

10/12/2022

Unavailable

current

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

10/12/2022

Limited Availablity

current

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

08/15/2023

Limited Availability

current

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

10/12/2022

Avaliable

Chemical Identity

CAS300-62-9
PubChem CID3007
DTXSIDDTXSID4022600
FormulaC9H13N
Mol. Weight135.21 g/mol
SMILESCC(CC1=CC=CC=C1)N

Data Sources

30072026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/amphetamine/cids/JSON

Archive: data/sources/pubchem_name/amphetamine.json

CAS 300-62-92026-04-24

https://www.epa.gov/tsca-inventory

Archive: data/sources/tsca/tsca_inventory.csv

CAS 300-62-92026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json